Upregulation of FasL and apoptosis in thymic lymphomas in Atm knock-in mice

Toxicology

Volumn 181-182, Issue , 2002, Pages 483-489

  Lavin, Martin F ^a,b   Spring, Kevin ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Atm; FasL; Knock in mice; Thymic lymphomas

Indexed keywords

ATM PROTEIN; FAS LIGAND; MUTANT PROTEIN; NUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DAMAGE; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENETIC MODEL; GENETIC STABILITY; KNOCKOUT MOUSE; LIFESPAN; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMUS LYMPHOMA; UPREGULATION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CHROMOSOME ABERRATIONS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE DELETION; GENETIC VECTORS; HOMOZYGOTE; IMMUNOBLOTTING; LYMPHOMA, T-CELL; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PHENOTYPE; PROTEIN KINASES; UP-REGULATION;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 18144435502     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00462-6     Document Type: Article

References (39)

1. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:1996;159-171.
2. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J. II, Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in organs. Proc. Natl. Acad. Sci. USA. 96:1999;9915-9919.
3. Beamish H., Lavin M.F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65:1994;175-184.
4. Beamish H., Williams R., Chen P., Khanna K.K., Hobson K., Watters D., Shiloh Y., Lavin M. Rapamycin resistance in ataxia-telangiectasia. Oncogene. 13:1996;963-970.
5. Belka C., Marini P., Budach W., Schulze-Osthoff K., Lang F., Gulbins E., Bamberg M. Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the upregulation of CD95/Fas/APO-1 ligand. Radiat. Res. 149:1998;588-595.
6. Borghesani P.R., Alt F.W., Bottaro A., Davidson L., Aksoy S., Rathbun G.A., Roberts T.M., Swat W., Segal R.A., Gu Y. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc. Natl. Acad. Sci. USA. 97:2000;3336-3341.
7. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
8. Chen P.C., Lavin M.F., Kidson C., Moss D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 274:1978;484-486.
9. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
10. Cornforth M.W., Bedford J.S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227:1985;1589-1591.
11. Cortez D., Wang Y., Qin J., Elledge S.J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
12. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;13084-13089.
13. Falck J., Mailand N., Syljuasen R.G., Bartek J., Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant synthesis. Nature. 410:2001;842-847.
14. Foray N., Priestley A., Alsbeih G., Badie C., Capulas E.P., Arlett C.F., Malaise E.P. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol. 72:1997;271-283.
15. Gatei M., Scott S.P., Filippovitch I., Soronika N., Lavin M.F., Weber B., Khanna K.K. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60:2000;3299-3304.
16. Gatei M., Shkedy D., Khanna K.K., Uziel T., Shiloh Y., Pandita T.K., Lavin M.F., Rotman G. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid. Oncogene. 20:2001;289-294.
17. Gotoff S.P., Amirmokri E., Liebner E.J. Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am. J. Dis. Child. 114:1967;617-625.
18. Herzog K.H., Chong M.J., Kapsetaki M., Morgan J.I., McKinnon P.J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1998;1089-1091.
19. Kastan M.B., Zhan Q., el-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 7:1992;587-597.
20. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:1995;5579-5588.
21. Kuljis R.O., Xu Y., Aguila M.C., Baltimore D. Degeneration of neurons, synapses, and neurophil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl. Acad. Sci. USA. 94:1997;12688-12693.
22. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Ann. Rev. Immunol. 15:1997;177-202.
23. Lavin M.F., Khanna K.K. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8:1993;3307-3312.
24. Lim D.S., Kirsch D.G., Canman C.E., Ahn J.H., Ziv Y., Newman L.S., Darnell R.B., Shiloh Y., Kastan M.B. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc. Natl. Acad. Sci. USA. 95:1998;10146-10151.
25. Morgan J.L., Holcomb T.M., Morrissey R.W. Radiation reaction in ataxia telangiectasia. Am. J. Dis. Child. 116:1968;557-558.
26. Petiniot L.K., Weaver Z., Barlow C., Shen R., Eckhaus M., Steinberg S.M., Ried T., Wynshaw-Boris A., Hodes R.J. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is essential for tumorigenesis in Atm-deficient mice. Proc. Natl. Acad. Sci. USA. 97:2000;6664-6669.
27. Sauer B., Henderson N. Targeted insertion of exogenous DNA into the eukaryotic genome by the Crc recombinase. New Biol. 2:1990;441-449.
28. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., et al. A single ataxia-telangiectasia gene with a product similar to PI3-kinase. Science. 268:1995;1749-1753.
29. Sedgwick R.P., Boder E. Vianney De Jong J.M.B. Hereditary Neuropathies and Spinocerebellar Atrophies. 1991;347-423 Alan R Liss Inc, New York.
30. Shiloh Y., Tabor E., Becker Y. Cellular hypersensitivity to neocarzinostatin in ataxia-telangiectasia skin fibroblasts. Cancer Res. 42:1982;2247-2249.
31. Spector E.B., Rice S.C., Moedjono S., Bernard B., Cederbaum S.D. Biochemical properties of aginase in human adult and fetal tissues. Biochem. Med. 28:1982;165-175.
32. Spring K., Cross S., Li C., Watters D., Ben-Senior L., Waring P., Ahangari F., Lu S.L., Chen P., Misko I., Paterson C., Kay G., Smorodinsky N.I., Shiloh Y., Lavin M.F. Atm knock-in-mice harbouring an in-frame detection corresponding to the human ATM 7636del9 mutation exhibit a variant A-T phenotype. Cancer Res. 61:2001;4561-4568.
33. Taylor A.M., Harnden D.G., Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S., Bridges B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258:1975;427-429.
34. Wang B., She J., Salio M., Allen D., Lacy E., Lonberg N., Terhorst C. CD3-epsilon overexpressed in prothymocytes acts as an oncogene. Mol. Med. 3:1997;72-81.
35. Watters D., Khanna K.K., Beamish H., Birrell G., Spring K., Kedar P., Gatei M., Stenzel D., Hobson K., Kozlov S., Zhang N., Farrell A., Ramsay J., Gatti R., Lavin M. Cellular localisation of the ataxia-telangiectasia (A-T) gene product and discrimination between mutated and normal forms. Oncogene. 14:1997;1911-1921.
36. Watters D., Kedar P., Spring K., Bjorkman J., Chen P., Gatei M., Birrell G., Garrone B., Srinivasa P., Crane D.I., Lavin M.F. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274:1999;34277-34282.
37. Westphal C.H., Rowan S., Schmaltz C., Elson A., Fisher D.E., Leder P. Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but resistance to acute radiation toxicity. Nat. Genet. 16:1997;397-401.
38. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422.
39. Zhang N., Chen P., Khanna K.K., Scott S., Gatei M., Kozlov S., Watters D., Spring K., Yen T., Lavin M.F. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc. Natl. Acad. Sci. USA. 94:1997;8021-8026.